Evaluation of the paediatric dose of chloroquine in the treatment of Plasmodium vivax malaria

BACKGROUND: Chloroquine (CQ) continues to be the first-line medication used worldwide in the treatment of Plasmodium vivax malaria. The dose recommended by the World Health Organization is 25 mg/kg independently of the age of the subject. Nonetheless, the pharmacokinetics and pharmacodynamics of dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Añez, Arletta, Moscoso, Manuel, Garnica, Cecilia, Ascaso, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950695/
https://www.ncbi.nlm.nih.gov/pubmed/27430284
http://dx.doi.org/10.1186/s12936-016-1420-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950695/
https://www.ncbi.nlm.nih.gov/pubmed/27430284
http://dx.doi.org/10.1186/s12936-016-1420-5

Ejemplares similares